Skip to main content
. Author manuscript; available in PMC: 2011 Aug 5.
Published in final edited form as: Hepatology. 2005 Nov;42(5):1194–1202. doi: 10.1002/hep.20907

Table 2.

Clinical Comorbidity and Surgical History of PBC Cases and Controls

Cases (%) (n = 1,032) Controls (%) (n = 1,041) Unadjusted P Value
History of comorbidities
 Rheumatoid arthritis 103 (10%) 83 (8%) .1292
 Systemic lupus erythematosus 27 (3%) 5 (0.5%) <.0001
 Autoimmune thyroid disease 93 (9%) 11 (1%) <.0001
 Raynaud syndrome 118 (12%) 23 (2%) <.0001
 Sjögren syndrome 102 (10%) 5 (0.5%) <.0001
 Scleroderma 24 (2%) 0 <.0001
 Polymyositis 6 (0.6%) 1 (0.1%) .0684
 Any of the above 323 (32%) 131 (13%) <.0001
 Diabetes mellitus 99 (10%) 119 (11%) .1744
 Hypercholesterolemia 582 (58%) 445 (46%) <.0001
 History of urinary tract infections 612 (59%) 536 (52%) .0003
 History of breast cancer* 31 (3%) 45 (5%) .1277
 Asthma 124 (12%) 141 (14%) NS
 Hay fever 141 (14%) 186 (18%) .0113
History of surgery
 Tonsillectomy 584 (57%) 518 (50%) 0.0018
 Appendectomy 257 (25%) 285 (27%) NS
 Gallbladder removal 278 (27%) 179 (17%) <0.0001
 Colon polyp removal 190 (18%) 132 (13%) 0.0003
 Uterine fibroid removal* 161 (17%) 140 (15%) 0.1491
 Ovarian cyst removal* 127 (13%) 121 (13%) NS
 Thyroid surgery 23 (2%) 23 (2%) NS
 Cesarean section* 117 (12%) 124 (13%) NS

NOTE. Only P values beyond the .2 level for the comparison between patient groups are reported.

Abbreviation: NS, nonsignificant.

*

Referred to female cases and controls only.